Category:

Canada’s patented drug regulator is delaying the implementation of new pricing guidelines until 2021, to make “significant changes” in response to feedback it received during public consultations...Changes to the patented medicines regulations, which were originally announced last year, were supposed to go into force on July 1, 2020...The delay was applauded by federal opposition Conservatives, who argued that the regulatory changes set aggressive price ceilings for some new therapies — particularly for rare disorders — that would all but ensure they would not be brought to the Canadian market...“I’m relieved that the voices of patients have been heard and the government has decided to delay the changes. However, we still have a lot of uncertainty and I expect the government to use this additional time to better consult with patients,” Conservative MP and party health critic Matt Jeneroux said in a statement...We could see a drug shortage if these changes go ahead as planned in six months. Canada will no longer be a competitive marketplace and drug companies will be reluctant to bring their therapies here...READ MORE

With the sudden financial hardship—such as sharp declines in revenues and cash flow due to the cancellation of elective procedures because of the COVID-19 pandemic—a greater number of health systems may fall short of agreements tied to their borrowing compared to prior years...As Moody's Investors Service analysts explain in a report released this week, more hospitals are likely to experience a "technical default," meaning they have not met required covenants connected to their borrowing agreements such as maintaining certain debt service coverage and days cash on hand...Hospitals' revenues have declined by an average of 30% to 40%...READ MORE

The Centers for Medicare & Medicaid Services is reducing insulin copays for seniors who are eligible for Medicare via an executive order from President Donald Trump...Participating enhanced Medicare Part D plans in 2021 will provide a broad set of insulins at a maximum $35 copay for a month’s supply of each type of insulin, the White House said in a fact sheet on the new initiative...CMS estimates that beneficiaries could save $446, or 66%, a year for their insulins, the agency said in a press release...READ MORE

The United States will end its relationship with the World Health Organization over the body’s handling of the coronavirus pandemic, U.S. President Donald Trump said on Friday, accusing the U.N. agency of becoming a puppet of China...The move to quit the Geneva-based body, which the United States formally joined in 1948, comes amid growing tensions between Washington and Beijing over the coronavirus outbreak...Speaking in the White House Rose Garden, Trump said Chinese officials “ignored their reporting obligations” to the WHO about the virus - that has killed hundreds of thousands of people globally - and pressured the agency to “mislead the world.”...READ MORE

The novel COVID-19 virus has now infiltrated our communities on a global scale, forcing pharmacies to quickly adapt in order to sustain operations in the new normal...pharmacies everywhere are experiencing a dramatic influx in demand, but dwindling supply of resources and staffing...in a world increasingly influenced by technology, there is ample opportunity to leverage automation within pharmacies that can not only improve operations and maximize efficiency, but support patient wellness while growing their business and profits...

Adherence Pouch Packaging
- unit-of-use packaging alone saved more than 46.5 minutes per 100 prescriptions filled compared to count-and-pour dispensing.

Medication Synchronization and Adherence
- pharmacies can adopt medication synchronization, meaning all of a patient’s prescriptions are synchronized to be refilled on the exact same day of the month, eliminating the need for separate call-ins and pickups...READ MORE

Amid worldwide clamor for Covid-19 medicines and vaccines, the European Medicines Agency is being urged by several international clinical evidence experts...to publish all trial data on the same day any product is authorized for use against the novel coronavirus...In a letter to the European regulator, four country directors from the independent watchdog Cochrane and leaders from Germany’s Institute for Quality and Efficiency in Health Care argued that it is critical to promptly release clinical study reports to support further research and proper medical care. The reports are go-to documents that contain myriad details about the methods and results of a clinical trial...READ MORE

After the FDA identified a likely carcinogen in samples of the broadly used diabetes med metformin, recalls appeared likely. Now it's official...The FDA said Thursday it had asked five metformin manufacturers to pull their extended-release metformin products, after pushing recalls of heartburn med Zantac and "sartan" blood pressure drugs for the same reason. A likely human carcinogen, N-Nitrosodimethylamine, was discovered in samples of all three...READ MORE

Major health groups raised alarm following the announcement Friday by President Donald Trump that the U.S. is terminating its relationship with the World Health Organization...Trump previously said he would cut funding to WHO, a United Nations agency that helps promote global health initiatives including addressing disease outbreaks. He said WHO has not pushed for accountability over its handling of the virus that is believed to have originated in Wuhan, China. He has also previously said WHO was slow to act in response to the COVID-19 pandemic...But organizations such as the American Medical Association and the Infectious Diseases Society of America condemned the move, saying it will make the work of fighting the global pandemic "dramatically more challenging."...READ MORE

The United States has supplied Brazil with 2 million doses of hydroxychloroquine for use against the coronavirus, the two governments said...despite medical warnings about risks associated with the anti-malaria drug...The White House released a joint announcement on the drug, whose use has been touted both by U.S. President Donald Trump and Brazilian President Jair Bolsonaro, just days after the World Health Organization suspended testing it in COVID-19 patients because of safety concerns...HCQ will be used as a prophylactic to help defend Brazil’s nurses, doctors and healthcare professionals against the virus. It will also be used as a therapeutic to treat Brazilians who become infected...READ MORE

Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects…But was there good reason for so much enthusiasm?...based on the information made available...there’s really no way to know how impressive — or not — the vaccine may be...While Moderna blitzed the media, it revealed very little information — and most of what it did disclose were words, not data...Even the figures the company did release don’t mean much on their own, because critical information — effectively the key to interpreting them — was withheld...Experts suggest we ought to take the early readout with a big grain of salt...READ MORE